1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
- β-adrenoceptor blockers and pulmonary function in the general population: the Rotterdam Study
- Moxifloxacin dosing in post-bariatric surgery patients
- Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease ( PHARMACOP): a randomized controlled trial
- 2013
- A pilot qualitative analysis of vancomycin dosing and monitoring in children at a Belgian teaching hospital
- Retrospective analysis of metastatic renal cell cancer patients treated with sunitinib and the role of possible interactions
- Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics: results from single oral dose studies in healthy volunteers
- 2012
- Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes
- 2011
- Pharmacokinetics of two formulations of omeprazole administered through a gastrostomy tube in patients with severe neurodevelopmental problems
- 2010
- Activity of aclidinium bromide, a new long-acting muscarinic antagonist: a phase I study
- 2009
- Single-dose pharmacokinetics and pharmacodynamics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects